Hepatitis D - Epidemiology Forecast to 2027

  • ID: 4520727
  • Report
  • 60 pages
  • DelveInsight
1 of 3
This report titled ‘Hepatitis D - Epidemiology Forecast to 2027’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Hepatitis D in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), Japan and China.

Geography Covered:
  • The United States
  • EU5 (Germany, France, Italy, Spain and the United Kingdom)
  • Japan
  • China
Study Period: 2016-2027

Hepatitis D Epidemiology

The Hepatitis D epidemiology division provide the insights about historical and current patient pool and forecasted trend for each of the 8 major countries. The epidemiology data for Hepatitis D are studied through all possible division to give a better understanding about the Disease scenario in 8MM. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Hepatitis D Epidemiology Segmentation

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology [total prevalent cases, prevalence by Severity (Fulminant, Acute & Chronic), Gender Specific prevalence, Age Specific prevalence and diagnosed cases] of Hepatitis D in the 8MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom), Japan and China from 2016-2027.

The report also provides the epidemiology trends observed in the 8MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

According to this research, total prevalent population of Hepatitis D in 8 major markets was estimated to be 10,546,938 in 2016.

Report Scope:
  • The report covers detailed overview of Hepatitis D explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The report provides the insight about the historical and forecasted patient pool of Hepatitis D in 8 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), Japan and China.
  • The Report assesses the disease risk and burden and highlights the unmet needs of the disease
  • The Report helps to recognize the growth opportunities in the 8MM with respect to the patient population
  • The report provides the segmentation of the disease epidemiology by severity (Fulminant, Acute & Chronic), Gender-Specific, Age-specific and diagnosed prevalent cases of Hepatitis D
Key Strengths:
  • 10 Year Forecast of Hepatitis D epidemiology
  • 8MM Coverage
  • Diagnosed Prevalent cases of Hepatitis D
  • Prevalent Cases according to segmentation: by severity (Fulminant, Acute & Chronic), Gender-Specific, Age-specific and diagnosed prevalent cases of Hepatitis D in 8MM
Key Assessments:
  • Patient Segmentation
  • Disease Risk & Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Key Insights

2. Disease Background and Overview: Hepatitis D
2.1. Introduction
2.2. Classification
2.3. Factors influencing Hepatitis D Progression
2.4. Disease Causes
2.5. HDV-Symptoms
2.6. Pathogenesis
2.7. Pathophysiology
2.8. HDV Diagnosis
2.9. Prevention

3. Epidemiology and Patient Population
3.1. Key Findings
3.2. 8MM Prevalent Population of Hepatitis D

4. Country Wise-Epidemiology of Hepatitis D
4.1. United States
4.1.1. Prevalent cases of Hepatitis D in the United States
4.1.2. Prevalent Population of Hepatitis D by severity
4.1.3. Gender Specific Hepatitis D Prevalence
4.1.4. Age Specific Hepatitis D Prevalence
4.1.5. Diagnosed cases of Chronic Hepatitis D
4.2. EU5
4.2.1. Prevalent Population of Hepatitis D in EU5
4.3. France
4.3.1. Prevalent Population of Hepatitis D
4.3.2. Prevalent Population of Hepatitis D by severity
4.3.3. Gender Specific Hepatitis D Prevalence
4.3.4. Age Specific Hepatitis D Prevalence
4.3.5. Diagnosed cases of Chronic Hepatitis D
4.4. Germany
4.4.1. Prevalent Population of Hepatitis D
4.4.2. Prevalent Population of Hepatitis D by severity
4.4.3. Gender Specific Hepatitis D Prevalence
4.4.4. Age Specific Hepatitis D Prevalence
4.4.5. Diagnosed cases of Chronic Hepatitis D
4.5. Italy
4.5.1. Prevalent Population of Hepatitis D
4.5.2. Prevalent Population of Hepatitis D by severity
4.5.3. Gender Specific Hepatitis D Prevalence
4.5.4. Age Specific Hepatitis D Prevalence
4.5.5. Diagnosed cases of Chronic Hepatitis D
4.6. Spain
4.6.1. Prevalent Population of Hepatitis D
4.6.2. Prevalent Population of Hepatitis D by severity
4.6.3. Gender Specific Hepatitis D Prevalence
4.6.4. Age Specific Hepatitis D Prevalence
4.6.5. Diagnosed cases of Chronic Hepatitis D
4.7. United Kingdom
4.7.1. Prevalent Population of Hepatitis D
4.7.2. Prevalent Population of Hepatitis D by severity
4.7.3. Gender Specific Hepatitis D Prevalence
4.7.4. Age Specific Hepatitis D Prevalence
4.7.5. Diagnosed cases of Chronic Hepatitis D
4.8. Japan
4.8.1. Prevalent Population of Hepatitis D
4.8.2. Prevalent Population of Hepatitis D by severity
4.8.3. Gender Specific Hepatitis D Prevalence
4.8.4. Age Specific Hepatitis D Prevalence
4.8.5. Diagnosed cases of Chronic Hepatitis D
4.9. China
4.9.1. Prevalent Population of Hepatitis D
4.9.2. Prevalent Population of Hepatitis D by severity
4.9.3. Gender Specific Hepatitis D Prevalence
4.9.4. Age Specific Hepatitis D Prevalence
4.9.5. Diagnosed cases of Chronic Hepatitis D

5. Appendix

6. Report Methodology
6.1. Sources Used

7. Capabilities

8. Disclaimer

9. About the Publisher

List of Tables
Table 1: 8MM, Historical & Forecasted Hepatitis D Prevalence, 2016-2027
Table 2: the United States, Historical & Forecasted Hepatitis D Prevalence, 2016-2027
Table 3: the United States, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2027
Table 4: the United States, Gender-Specific Hepatitis D Prevalence, 2016-2027
Table 5: the United States, Age-Specific Hepatitis D Prevalence, 2016-2027
Table 6: the United States, Diagnosed cases of Hepatitis D, 2016-2027
Table 7: EU5, Historical & Forecasted Hepatitis D Prevalence, 2016-2027
Table 8: France, Historical & Forecasted Hepatitis D Prevalence, 2016-2027
Table 9: France, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2027
Table 10: France, Gender Specific Hepatitis D Prevalence, 2016-2027
Table 11: France, Age Specific Hepatitis D Prevalence, 2016-2027
Table 12: France, Diagnosed cases of Hepatitis D, 2016-2027
Table 13: Germany, Historical & Forecasted Hepatitis D Prevalence, 2016-2027
Table 14: Germany, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2027
Table 15: Germany, Gender-Specific Hepatitis D Prevalence, 2016-2027
Table 16: Germany, Age-Specific Hepatitis D Prevalence, 2016-2027
Table 17: Germany, Diagnosed cases of Hepatitis D, 2016-2027
Table 18: Italy, Historical & Forecasted Hepatitis D Prevalence, 2016-2027
Table 19: Italy, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2027
Table 20: Italy, Gender-Specific Hepatitis D Prevalence, 2016-2027
Table 21: Italy, Age-Specific Hepatitis D Prevalence, 2016-2027
Table 22: Italy, Diagnosed cases of Hepatitis D, 2016-2027
Table 23: Spain, Historical & Forecasted Hepatitis D Prevalence, 2016-2027
Table 24: Spain, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2027
Table 25: Spain, Gender Specific Hepatitis D Prevalence, 2016-2027
Table 26: Spain, Age Specific Hepatitis D Prevalence, 2016-2027
Table 27: Spain, Diagnosed cases of Hepatitis D, 2016-2027
Table 28: the United Kingdom, Historical & Forecasted Hepatitis D Prevalence, 2016-2027
Table 29: the United Kingdom, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2027
Table 30: the United Kingdom, Gender Specific Hepatitis D Prevalence, 2016-2027
Table 31: the United Kingdom, Age-Specific Hepatitis D Prevalence, 2016-2027
Table 32: the United Kingdom, Diagnosed cases of Hepatitis D, 2016-2027
Table 33: Japan, Historical & Forecasted Hepatitis D Prevalence, 2016-2027
Table 34: Japan, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2027
Table 35: Japan, Gender Specific Hepatitis D Prevalence, 2016-2027
Table 36: Japan, Age Specific Hepatitis D Prevalence, 2016-2027
Table 37: Japan, Diagnosed cases of Hepatitis D, 2016-2027
Table 38: China, Historical & Forecasted Hepatitis D Prevalence, 2016-2027
Table 39: China, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2027
Table 40: China, Gender Specific Hepatitis D Prevalence, 2016-2027
Table 41: China, Age Specific Hepatitis D Prevalence, 2016-2027
Table 42: China, Diagnosed cases of Hepatitis D, 2016-2027

List of Figures
Figure 1: Hepatitis Delta Virus Structure
Figure 2: Pathogenesis of Hepatitis D
Figure 3: Diagnostic markers in various hepatitis D disease patterns
Figure 4: 8MM, Historical & Forecasted Hepatitis D Prevalence, 2016-2027
Figure 5: the United States, Historical & Forecasted Hepatitis D Prevalence, 2016-2027
Figure 6: the United States, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2027
Figure 7: the United States, Gender-Specific Hepatitis D Prevalence, 2016-2027
Figure 8: the United States, Age Specific Hepatitis D Prevalence, 2016-2027
Figure 9: the United States, Diagnosed cases of Hepatitis D, 2016-2027
Figure 10: EU5, Historical & Forecasted Hepatitis D Prevalence, 2016-2027
Figure 11: France, Historical & Forecasted Hepatitis D Prevalence, 2016-2027
Figure 12: France, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2027
Figure 13: France, Gender Specific Hepatitis D Prevalence, 2016-2027
Figure 14: France, Age-specific Hepatitis D Prevalence, 2016-2027
Figure 15: France, Diagnosed cases of Hepatitis D, 2016-2027
Figure 16: Germany, Historical & Forecasted Hepatitis D Prevalence, 2016-2027
Figure 17: Germany, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2027
Figure 18: Germany, Gender-Specific Hepatitis D Prevalence, 2016-2027
Figure 19: Germany, Age-Specific Hepatitis D Prevalence, 2016-2027
Figure 20: Germany, Diagnosed cases of Hepatitis D, 2016-2027
Figure 21: Italy, Historical & Forecasted Hepatitis D Prevalence, 2016-2027
Figure 22: Italy, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2027
Figure 23: Italy, Gender-Specific Hepatitis D Prevalence, 2016-2027
Figure 24: Italy, Age-Specific Hepatitis D Prevalence, 2016-2027
Figure 25: Italy, Diagnosed cases of Hepatitis D, 2016-2027
Figure 26: Spain, Historical & Forecasted Hepatitis D Prevalence, 2016-2027
Figure 27: Spain, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2027
Figure 28: Spain, Gender Specific Hepatitis D Prevalence, 2016-2027
Figure 29: Spain, Age Specific Hepatitis D Prevalence, 2016-2027
Figure 30: Spain, Diagnosed cases of Hepatitis D, 2016-2027
Figure 31: the United Kingdom, Historical & Forecasted Hepatitis D Prevalence, 2016-2027
Figure 32: the United Kingdom, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2027
Figure 33: the United Kingdom, Gender-Specific Hepatitis D Prevalence, 2016-2027
Figure 34: the United Kingdom, Age Specific Hepatitis D Prevalence, 2016-2027
Figure 35: the United Kingdom, Diagnosed cases of Hepatitis D, 2016-2027
Figure 36: Japan, Historical & Forecasted Hepatitis D Prevalence, 2016-2027
Figure 37: Japan, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2027
Figure 38: Japan, Gender Specific Hepatitis D Prevalence, 2016-2027
Figure 39: Japan, Age Specific Hepatitis D Prevalence, 2016-2027
Figure 40: Japan, Diagnosed cases of Hepatitis D, 2016-2027
Figure 41: China, Historical & Forecasted Hepatitis D Prevalence, 2016-2027
Figure 42: China, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2027
Figure 43: China, Gender Specific Hepatitis D Prevalence, 2016-2027
Figure 44: China, Age Specific Hepatitis D Prevalence, 2016-2027
Figure 45: China, Diagnosed cases of Hepatitis D, 2016-2027
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll